5-HT(2B)-receptor antagonist LY-272015 is antihypertensive in DOCA- salt-hypertensive rats

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 276, Issue 3 45-3, 1999, Pages

  Watts, Stephanie W ^a   Fink, Gregory D ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

5 hydroxytryptamine; Deoxycorticosterone acetate; Experimental hypertension; Serotonin receptors; Vasoconstriction

Indexed keywords

DEOXYCORTICOSTERONE ACETATE; SEROTONIN ANTAGONIST; 1 (5 (2 THENYLOXY) 1H INDOL 3 YL)PROPAN 2 AMINE; 1-(5-(2-THENYLOXY)-1H-INDOL-3-YL)PROPAN-2-AMINE; ANTIHYPERTENSIVE AGENT; DEOXYCORTICOSTERONE; INDOLE DERIVATIVE; LY 272015; ORGANIC COMPOUND; SEROTONIN; SEROTONIN AGONIST; SODIUM CHLORIDE; THIOPHENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTERY MUSCLE; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ENDOTHELIUM CELL; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; STOMACH FUNDUS; VASOCONSTRICTION; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; GASTROINTESTINAL MOTILITY; MALE; MESENTERIC ARTERY; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DESOXYCORTICOSTERONE; GASTRIC FUNDUS; GASTROINTESTINAL MOTILITY; HYPERTENSION; INDOLES; MALE; MESENTERIC ARTERIES; ORGANIC CHEMICALS; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SODIUM CHLORIDE; THIOPHENES; TIME FACTORS; VASOCONSTRICTION;

EID: 0033093789     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1999.276.3.h944     Document Type: Article

References (38)

1. 2B) contractile receptor in the rat stomach fundus. J. Med. Chem. 39: 2773-2780, 1996.
2. Baez, M., J. D. Kursar, L. A. Helton, D. B. Wainscott, and D. L. Nelson. Molecular biology of serotonin receptors. Obes. Res. 3: 441S-447S, 1995.
3. 2A receptor mRNA density and contractility in trachea and aorta from guinea pig and rat. Life Sci. 55: PL105-PL114, 1994.
4. Cohen, M. L., R. W. Fuller, and K. D. Kurz. Evidence that blood pressure reduction by serotonin antagonists is related to alpha receptor blockade. Hypertension 5: 676-681, 1983.
5. 2B receptor antagonist. J. Ser. Res. 3: 131-144, 1996.
6. Cummings, S. A., R. J. Groszmann, and A. J. Kaumann. Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats. Br. J. Pharmacol. 89: 501-513, 1986.
7. Dawson, R., S. Nagamhama, and S. Oparil. Central serotonergic alterations in deoxycorticosterone acetate/NaCl (DOCA/NaCl)-induced hypertension. Neuropharmacology 27: 417-426, 1988.
8. Donaldson, L. F., M. R. Hanley, and A. C. Villablanca. Inducible receptors. Trends Pharmacol. Sci. 18: 171-181, 1997.
9. 2B receptors in the medial amygdala causes anxiolysis in social interaction test in the rat. Neuropharmacology 36: 601-608, 1997.
10. Ellis, E. S., C. Byrne, O. E. Murphy, N. S. Tilford, and G. S. Baxter. Mediation by 5-hydroxytryptamine2B receptors of endothelium-dependent relaxation in rat jugular vein. Br. J. Pharmacol. 114: 400-404, 1995.
11. Foguet, M., D. Hoyer, L. A. Pardo, A. Parekh, F. W. Kluxen, O. Kalkman, W. Stuhmer, and H. Lubbert. Cloning and functional expression of the rat stomach fundus serotonin receptor. EMBO J. 11: 3481-3487, 1992.
12. Glusa, E., and A. Roos. Endothelial 5-HT receptors mediate relaxation of porcine pulmonary arteries in response to ergotamine and dihydroergotamine. Br. J. Pharmacol. 119: 330-334, 1996.
13. Hoyer, D., D. E. Clarke, J. R. Fozard, P. R. Hartig, G. R. Martin, W. J. Mylecharane, P. R. Saxena, and P. P. A. Humphrey. International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46: 158-203, 1994.
14. Ito, A., K. Egashira, T. Kadokami, Y. Fukumoto, T. Takayanagi, R. Nakaike, T. Kuga, K. Sueishi, H. Shimokawa, and A. Takeshita. Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular structural changes and hyperreactivity to serotonin in pigs. Circulation 92: 2636-2644, 1995.
15. 3H-serotonin and endogenous content of serotonin in blood platelets in hypertensive patients. Hypertension 6: 568-573, 1984.
16. Kavanaugh, W. M., L. T. Williams, H. E. Ives, and S. R. Coughlin. Serotonin-induced deoxyribonucleic acid synthesis in vascular smooth muscle cells involves a novel, pertussis toxin-sensitive pathway. Mol. Endocrinol. 2: 599-605, 1988.
17. 2F) from rat stomach fundus. Mol. Pharmacol. 42: 549-557, 1992.
18. 2B receptor. J. Biol. Chem. 271: 3141-3147, 1996.
19. Loric, S., L. Maroteaux, O. Kellermann, and J. M. Launay. Functional serotonin-2B receptors are expressed by a teratocarcinoma-derived cell line during serotoninergic differentiation. Mol. Pharmacol. 47: 458-466, 1995.
20. MacLean, M. R., G. Sweeney, M. Baird, K. M. McCulloch, M. Houslay, and I. Morecroft. 5-Hydroxytryptamine receptor mediating vasoconstriction in pulmonary arteries from control and pulmonary hypertensive rats. Br. J. Pharmacol. 119: 917-930, 1996.
21. MacLennan, S. J., M. L. Bolofo, and G. R. Martin. Amplifying interactions between spasmogens in vascular smooth muscle. Biochem. Soc. Trans. 21: 1145-1150, 1993.
22. Marwood, J. F., and G. S. Stokes. Serotonin (5-HT) and its antagonists: involvement in the cardiovascular system. Clin. Exp. Pharmacol. Physiol. 11: 439-456, 1984.
23. McGregor, D. D., and F. H. Smirk. Vascular responses to 5-hydroxytryptamine in genetic and renal hypertensive rats. Am. J. Physiol. 219: 687-690, 1970.
24. Myers, J. H., T. E. Mecca, and R. C. Webb. Direct and sensitizing effects of serotonin agonists and antagonists on vascular smooth muscle. J. Cardiovasc. Pharmacol. 7: S44-S48, 1985.
25. Roson, M. I., M. K. Maquieira, and I. J. de la Riva. Contrasting effects of norepinephrine and 5-hydroxytryptamine on contractility of abdominal aorta of two kidney-two clip hypertensive rats. Effects of inhibitors of arachidonic acid metabolic enzymes. Clin. Exp. Hypertens. A12: 285-306, 1990.
26. 2B serotonin receptor. FEBS Lett. 342: 85-90, 1994.
27. 2B receptors: an early step in the generation of migraine headache? Eur. J. Neurosci. 8: 959-967, 1996.
28. Szabo, C., J. E. Hardebo, and C. Owman. An amplifying effect of exogenous and neuronally stored 5-hydroxytryptamine on the neurogenic contraction in rat tail artery. Br. J. Pharmacol. 102: 401-407, 1991.
29. Thompson, L. P., and R. C. Webb. Vascular responsiveness to serotonin metabolites in mineralocorticoid hypertension. Hypertension 9: 277-281, 1987.
30. Vane, J. R. A sensitive method for the assay of 5-hydroxytryptamine. Br. J. Pharmacol. 12: 344-349, 1957.
31. Vanhoutte, P. M. Serotonin, hypertension and vascular disease. Neth. J. Med. 38: 35-42, 1991.
32. Vanhoutte, P., A. Amery, W. Birkenhager, A. Breckenridge, F. Buhler, A. Distler, J. Dormandy, A. Doyle, E. Frohlich, L. Hansson, T. Hedner, N. Hollenberg, H.-E. Jensen, P. Lund-Johansen, P. Meyer, L. Opie, I. Robertson, M. Safar, M. Schalekamp, J. Symoens, J. Trap-Jensen, and A. Zanchetti. Serotoninergic mechanisms in hypertension. Focus on the effects of ketanserin. Hypertension 11: 111-133, 1988.
33. 2F receptor. Mol. Pharmacol. 43: 419-426, 1993.
34. 2B receptor: evidence for species differences. J. Pharmacol. Exp. Ther. 276: 720-727, 1996.
35. Watts, S. W. The development of enhanced arterial serotonergic hyperresponsiveness in mineralocorticoid hypertension. J. Hypertens. 16: 811-822, 1998.
36. 2B receptor antagonist LY272015 inhibits 5-HT-induced contraction in the aorta of mineralocorticoid-salt hypertensive rats. J. Ser. Res. In press.
37. Watts, S. W., M. Baez, and R. C. Webb. The 5-hydroxytryptamineae receptor and 5-HT receptor signal transduction in mesenteric arteries from deoxycorticosterone acetate-salt hypertension. J. Pharmacol. Exp. Ther. 277: 1103-1113, 1996.
38. 2B receptor mediates contraction in the mesenteric artery of mineralocorticoid hypertensive rats. Hypertension 26: 1056-1059, 1995.